New study aims to unravel mysteries of immune disorder complications

NCT ID NCT07526714

Not yet recruiting Knowledge-focused Sponsor: Central Hospital, Nancy, France Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks back at medical records of about 60 people with primary immune deficiencies who also developed lymphoproliferative disorders (abnormal growth of immune cells). The goal is to track their health over time, including risks of death, cancer, or organ damage. By identifying patterns and risk factors, researchers hope to improve monitoring and care for this group.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BENIGN LYMPHOPROLIFERATIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inborn error of immunity Lymphadenopathy lymphoproliferative syndrome Primary Immunodeficiency Diseases Splenomegaly

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BENIGN LYMPHOPROLIFERATIVE DISORDER PRIMARY IMMUNE DEFICIENCIES

More trials for these conditions

Other studies related to the condition(s) this trial covers.